Publication | Closed Access

Lazaroid compounds prevent early but not late stages of oxidant-induced cell injury: potential explanation for the lack of efficacy of lazaroids in clinical trials

Chemoprevention StrategyMedicineImmunologyClinical TrialsPharmacotherapyLate StagesAnti-cancer AgentPharmacologyOxidant-induced Cell InjuryOxidative Stress